Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (unaudited)

v3.24.3
Condensed Consolidated Statements of Operations (unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 169 $ 182 $ 505 $ 546
Selling, general and administrative 27 30 82 91
Total operating expenses 196 212 587 637
Loss from operations (196) (212) (587) (637)
Other income (expense):        
Change in fair value of derivative liabilities (28) 5 (15) (7)
Other income, net 16 17 47 40
Loss before income taxes (208) (190) (555) (604)
Income tax expense 0 0 0 0
Net loss $ (208) $ (190) $ (555) $ (604)
Basic net loss per share (in usd per share) $ (0.13) $ (0.13) $ (0.35) $ (0.48)
Diluted net loss per share (in usd per share) $ (0.13) $ (0.13) $ (0.35) $ (0.48)
Basic weighted-average shares outstanding (in shares) 1,657 1,432 1,582 1,261
Diluted weighted-average shares outstanding (in shares) 1,657 1,432 1,582 1,261